BASE10 Collaborates with DNA Link to Support Authorization of COVID-19 IgG Antibody Test at the Point of Care

Shots:

  • The companies collaborated to evaluate the usability of DNA Link’s AccuFind COVID-19 IgG antibody test in a healthcare setting
  • The study intends to expand access to antibody testing outside of laboratory settings
  • The companies plan to launch the study in Dec’2020

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Base 10 genetics

The post BASE10 Collaborates with DNA Link to Support Authorization of COVID-19 IgG Antibody Test at the Point of Care first appeared on PharmaShots.